Results 101 to 110 of about 4,617,323 (138)

Assay for ADAMTS-13 Activity with Flow Cytometric Readout. [PDF]

ACS Omega, 2022
Müller J, Hamedani NS, McRae HL, Rühl H, Oldenburg J, Pötzsch B.   +5 more
europepmc   +1 more source

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

, 2004
The congenital or acquired deficiency of the von Willebrand factor (VWF) cleaving protease, ADAMTS-13 has been specifically associated with a diagnosis of thrombotic thrombocytopenic purpura (TTP), a microangiopathy characterized by the formation of ...
S. Lavoretano, P.M. Mannucci, M. T. Canciani, S. Ferrari, F. Peyvandi   +4 more
core   +1 more source

The von Willebrand factor - ADAMTS-13 axis in malaria. [PDF]

Res Pract Thromb Haemost, 2022
O'Donnell AS, Fazavana J, O'Donnell JS.
europepmc   +1 more source

Proteolysis of ADAMTS-13 by thrombin does not influence the cleavage of, or binding to, VWF115

, 2011
(A) 5 n ADAMTS-13 or thrombin-cleaved ADAMTS-13 (ADAMTS-13/FIIa) was incubated at 37 °C with 5 μ VWF115, 150 m NaCl, 5 m CaCl, 20 m Tris (pH7.8).
C K N K CHION (48919), S ZANARDELLI (48920), J T B CRAWLEY (48922), J K LAM (48918), D A LANE (48921)   +4 more
core   +1 more source

Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay. [PDF]

Res Pract Thromb Haemost, 2023
Bonnez Q, Dekimpe C, Tellier E, Kaplanski G, Verhamme P, Tersteeg C, De Meyer SF, Lammertyn J, Joly B, Coppo P, Veyradier A, Vanhoorelbeke K.   +11 more
europepmc   +1 more source

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency

, 2005
Summary. Background: Accurate estimates of the incidence of thrombotic thrombocytopenic purpura (TTP) are important to assess the resources required for current treatments as well as to anticipate the need to develop new treatments.
George, J. N., Vesely, S. K., Terrell, D. R., Williams, L. A., Lämmle, B, Hovinga, J. A. K.   +5 more
core   +1 more source

Anti-inflammatory protective effect of ADAMTS-13 in murine arthritis models. [PDF]

J Thromb Haemost, 2022
Fukui S, Gutch S, Fukui S, Chu L, Wagner DD.   +4 more
europepmc   +1 more source

A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometry. [PDF]

Res Pract Thromb Haemost, 2023
Pillai VG, Zheng XL.
europepmc   +1 more source

Serum biomarkers reflecting progression of knee osteoarthritis: a stage-based evaluation of TGF-β3, ADAMTS-4, ADAMTS-5, and MMP-13

BMC Musculoskeletal Disorders
Background Knee osteoarthritis (KOA) is a progressive degenerative joint disease characterized by extracellular matrix (ECM) degradation and dysregulated inflammatory signaling.
Omer Esmez, Zubeyde Ercan, Secil Yılmaz, Meryem Sedef Doğru   +3 more
doaj   +1 more source

Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease. [PDF]

J Clin Med, 2022
Dolgushina N, Gorodnova E, Beznoshenco O, Romanov A, Menzhinskaya I, Krechetova L, Sukhikh G.   +6 more
europepmc   +1 more source